Active immunotherapy may delay disability in progressive MS.

Abstract

In this issue of the journal, an epidemiological study using global multiple sclerosis (MS) database is published that investigated prognostic factors in advanced stages of MS. The cohort analysed included prospectively collected data of over 3000 patients with MS, and among various factors comprised demographics, age at onset, disease duration, annualised… (More)
DOI: 10.1136/jnnp-2016-314377

Topics

Cite this paper

@article{Haghikia2017ActiveIM, title={Active immunotherapy may delay disability in progressive MS.}, author={Aiden Haghikia and Ralf Gold}, journal={Journal of neurology, neurosurgery, and psychiatry}, year={2017}, volume={88 3}, pages={193} }